(Q44723249)

English

Death receptor 5 and Bcl-2 protein expression as predictors of tumor response to gemcitabine and cisplatin in patients with advanced non-small-cell lung cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Death receptor 5 and Bcl-2 protein expression as predictors of tumor response to gemcitabine and cisplatin in patients with advanced non-small-cell lung cancer (English)

1 reference

Europe PubMed Central

5 December 2017

1 reference

based on heuristic

inferred from title

author name string

Ji-Youn Han

1

1 reference

Europe PubMed Central

5 December 2017

Eun Kyung Hong

2

1 reference

Europe PubMed Central

5 December 2017

Byung Gil Choi

3

1 reference

Europe PubMed Central

5 December 2017

Jin No Park

4

1 reference

Europe PubMed Central

5 December 2017

Ki Won Kim

5

1 reference

Europe PubMed Central

5 December 2017

Jin Hyung Kang

6

1 reference

Europe PubMed Central

5 December 2017

Jong-Youl Jin

7

1 reference

Europe PubMed Central

5 December 2017

Suk Young Park

8

1 reference

Europe PubMed Central

5 December 2017

Young Seon Hong

9

1 reference

Europe PubMed Central

5 December 2017

Kyung Shik Lee

10

1 reference

Europe PubMed Central

5 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

5 December 2017

Medical Oncology

1 reference

Europe PubMed Central

5 December 2017

20

1 reference

Europe PubMed Central

5 December 2017

355-362

1 reference

Europe PubMed Central

5 December 2017

4

1 reference

Europe PubMed Central

5 December 2017

https://scigraph.springernature.com/pub.10.1385/mo:20:4:355

0 references

Apoptosis and drug response

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TRAIL, Fasl and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Death and anti-death: tumour resistance to apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of apoptosis by gemcitabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 and Bcl-2 expression in pneumoconiosis-related pre-cancerous lesions and lung cancers: frequent and preferential p53 expression in pneumoconiotic bronchiolar dysplasias

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivating mutations of KILLER/DR5 gene in gastric cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between cisplatin-induced apoptosis and p53, bcl-2 and bax expression in human lung cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content

1 reference

https://pubmed.ncbi.nlm.nih.gov/14716031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1385/MO:20:4:355

1 reference

Europe PubMed Central

5 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44723249&oldid=2034605321"